Guardant Health reports Q1 2026 non-GAAP EPS -0.85 and revenue $301.7M (+48% YoY), misses EPS but beats revenue estimates, raises 2026 revenue guidance to $1.30–$1.32B
https://finviz.com/quote?t=GH&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.